Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
Emilie Seydoux, Leah J. Homad, Anna J. MacCamy, K. Rachael Parks, Nicholas K. Hurlburt, Madeleine F. Jennewein, Nicholas R. Akins, Andrew B. Stuart, Yu-Hsin Wan, Junli Feng, Rachael E. Whaley, Suruchi Singh, Michael Boeckh, Kristen W. Cohen, M. Juliana McElrath, Janet A. Englund, Helen Y. Chu, Marie Pancera, Andrew T. McGuire, Leonidas Stamatatos
Topics & Concepts
VirologyBiologySomatic cellNeutralizing antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MutationAntibodyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakGeneticsVirusGeneMedicineInfectious disease (medical specialty)OutbreakPathologyDiseaseSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchMonoclonal and Polyclonal Antibodies Research